24/5/2021

Pulsiv appoints Darrel Kingham as CEO and completes £1.5 million fundraising

Portfolio company Pulsiv announces significant steps to accelerate development, prepare for scale up and deploy its unique power conversion technology.

Read more

19/5/2021

Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb

Portfolio company Exscientia has entered into a collaboration agreement with Bristol Myers Squibb, with upfront and potential milestones of up to $1.2 billion in addition to tiered royalties.

Read more

6/5/2021

The Vaccine Group appoints Jeremy Salt as Chief Executive Officer

Former Chief Scientific Officer of GALVmed and director of Biologicals R&D for Europe, Africa and Middle East of the world’s largest animal health group Zoetis to lead TVG through next phase of development.

Read more

28/4/2021

Frontier IP: full year outcome “materially ahead of management expectations”

The Group is pleased to provide an update on trading for the year ending 30 June 2021. Following a strong first half, the portfolio continues to make good commercial and technical progress, including an uplift in the value of our holding in Exscientia.

Read more

28/4/2021

Exscientia announces investment of up to $525m led by SoftBank

Our portfolio company Exscientia has completed a Series D funding round led by SoftBank Vision Fund 2 to expand its pipeline and AI-driven drug discovery capabilities.

Read more

7/4/2021

Emporia4KT launches technology transfer training programme

Sixty researchers have begun an 11-month training programme to hone their technology transfer skills within Blue Economy sectors. The has been organised by Emporia4KT, a major project to maximise the value of academic research to Europe’s marine and coastal economies in which Frontier IP is a partner.

Read more

24/3/2021

Frontier IP looks to the future with confidence

Strong interim results, with several portfolio companies now on the cusp of important inflection points reflecting the significant commercial, technical and industrial progress they made during the first half and beyond.

Read more

19/3/2021

Fieldwork Robotics raises £675,000 to accelerate development of harvesting robots

Fieldwork Robotics has raised £675,000 to accelerate scale up of its raspberry harvesting robot technology and to start development of a cauliflower harvester in collaboration with Bonduelle, one of the world’s leading vegetable producers.

Read more

15/3/2021

Chief Executive Neil Crabb: talking tech transfer with the Global University Venturing podcast

Frontier IP Chief Executive Neil Crabb discusses why our commercialisation approach differs, clusters, why it’s important there are different models out there and our expansion in Portugal.

Read more

11/3/2021

Portugal Ventures backs inSignals Neurotech with €100,000 investment

Portfolio company inSignals Neurotech has received a €100,000 investment from leading Portuguese venture capital firm Portugal Ventures to accelerate development of its patented technology to aid deep brain simulation surgery.

Read more
Frontier Ip Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.